Companies / Costa Rica
Costa Rica Introduces Generic Equivalence Rules
February 2006 | Company Finance AlertCosta Rica's health ministry has introduced new rules obliging drugmakers to prove therapeutic equivalence for generic products in regulatory submissions. The regulations became effective on February 4, updating previous rules, which only called for stability, dissolution and organoleptic tests.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
